J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like Retrophin to Close Down Cambridge Operations, Cut Jobs in Consolidation Move March 8, 2017 Celgene Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia January 25, 2017 Investors Antsy as Novartis AG Mulls Over Selling $50 Billion in Assets May 29, 2017